MABTAS INJ-100mg
MABTAS Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.
| Manufacturer /Marketed by | Intas |
|---|---|
| Contains / Molecules | RITUXIMAB |
| Strength | 100mg |
| Packing | 10 ml in 1 vial |
| International Name | MABTAS INJ-100mg |
